# HOOKIPA Pharma Inc. — Form D

HOOKIPA Pharma Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-27. $37.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-02-27
- Form: D
- Accession: 0001760542-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $37.4M
- Investors: 9
- Date of first sale: 2019-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333647

## Issuer

- Name: HOOKIPA Pharma Inc.
- CIK: 0001760542
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 430 EAST 29TH STREET, NEW YORK, NY, 10016
- Phone: 0114318906360

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Joern Aldag | Director | NEW YORK, NY |
| Reinhard Kandera | Director | NEW YORK, NY |
| Michael Kelly | Director | NEW YORK, NY |
| Paul-Henri Lambert | Director | NEW YORK, NY |
| Christoph Lengauer | Director | Cambridge, MA |
| Julie O'Neill | Director | Chatillon, I0 |
| Graziano Seghezzi | Director | Paris, I0 |
| Sander van Deventer | Director | NEW YORK, NY |
| Jan van de Winkel | Director | NEW YORK, NY |
| Joern Aldag | Executive Officer | NEW YORK, NY |
| Reinhard Kandera | Executive Officer | NEW YORK, NY |

## More

- [CIK 1760542 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1760542&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001760542-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.